Above & Beyond
A family of five embarks on an 800-mile journey to help find new treatments for cystic fibrosis and a brighter future for their daughter.
CF Drug Development Takes a Giant Step Forward
CF Foundation President and CEO Robert J. Beall, Ph.D., discusses breakthrough results of the late-stage trial of VX-770, a potential therapy that treats the underlying cause of cystic fibrosis.
Sometimes Two Is Better Than One
A new study of the combination of two potential drugs targeting the basic defect is underway for patients with the most common genetic mutation of CF, Delta F508. Lead researcher Dr. Michael Boyle explains.
New Law Opens Doors for CF Clinical Trial Volunteers
A new law championed by CF Foundation volunteers will allow more people with CF to participate in clinical trials.